The Healthy on MSN6h
“Here’s What Happened When I Stopped Taking Ozempic”: One Patient’s Story Navigating a New Normal
Did she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who ...
Embecta Corp.: Navigating Through A Changing Landscape
Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...
RIPR: The Public's Radio20h
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The American Journal of Managed Care2d
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
Medscape3d
Fridays and Snacking Bad for Smart Insulin Pen Adherence
MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...
WebMD5d
Considering Zepbound in Vials? Here Are Some Starter Tips
The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...